#USA #London #AI Innovation #Clarivate #Value Creation

Clarivate Reports Third Quarter 2026 Results

On November 3, 2026, Clarivate Plc (NYSE: CLVT), a prominent global provider of transformative intelligence, unveiled its financial outcomes for the third quarter ended September 30, 2026. The report showcases a strategic path focused on improving recurring organic revenue as well as innovative advancements driven by artificial intelligence (AI).

Performance Overview

The third-quarter results reflect a positive momentum, revealing improved key metrics, specifically in the organic recurring revenue category, which grew by 0.4%. The Intellectual Property (IP) segment has shown signs of recovery with a return to positive Annual Contract Value (ACV) growth. The company’s Chief Executive Officer, Matti Shem Tov, remarked that the early closure of the Life Sciences & Healthcare (LSH) segment divestiture signifies a decisive move toward amplifying value creation within their core sectors: Academia & Government and Intellectual Property.

Financial Highlights

In the reported quarter, Clarivate's total revenues amounted to $567.9 million, including contributions from the divested LSH segment, which previously generated $623.1 million in the third quarter of 2025. Without the LSH figures, revenues for the continuing operations reached $481.6 million, down from $530.3 million the previous year, mainly due to inorganic disposals.

• - Net loss stood at $80.8 million or $0.13 loss per diluted share, compared to a loss of $28.3 million or $0.04 per diluted share in Q3 2025, attributed significantly to a non-cash goodwill impairment charge of $62.2 million from the LSH segment.
• - Adjusted net income was reported at $136.0 million at $0.21 per diluted share, a notable increase from $119.3 million or $0.18 per diluted share year-on-year.
• - Adjusted EBITDA came in at $245.3 million, marginally dropping from $252.4 million in Q3 2025, while the margins hovered around the mid-40% range.

First Nine Months of 2026

As for the first three quarters of 2026, total revenues amounted to $1.740.7 billion, which represented a decrease from $1.838.2 billion compared to 2025, caused primarily by the LSH divestitures. Excluding LSH, the total revenue figures dropped to $1.472.4 billion from $1.546.7 billion, demonstrating a trend consistent across the transitioning phases of the business.

The organic revenue growth for continuing operations was stable at 0.1%. The increase in organic subscription revenues by 0.9% was counterbalanced by a decline initiated in transactional revenue streams.

Cash Flow and Financial Health

In terms of cash flow, Clarivate generated $399.0 million from operating activities in the first nine months, alongside a free cash flow of $233.1 million, indicative of ongoing effective management of cash resources.

Market Outlook

Looking forward, the full-year financial outlook for 2026 anticipates revenue growth between $1.965 billion and $1.985 billion, along with sustained improvements in recurring organic revenue growth expected to be around 1.00% to 1.50%. For the fourth quarter, projections indicate revenues between $490 million to $510 million.

The company continues to adopt a disciplined approach in capital allocation while focusing on organic growth, which, as per CFO Michael Easton, is vital in translating revenue into sustainable earnings and additional cash flow. This approach helps bolster their financial profile and enhances flexibility amidst evolving market dynamics.

In conclusion, Clarivate’s third-quarter results reflect a strong commitment to strategic growth through product innovation and operational efficiency, setting the stage for a promising future amidst recent transformations.